Kurita Tadayoshi, Kazama Tomiei, Morita Koji, Fujii Shunsuke, Uraoka Masahiro, Takata Kotaro, Sato Shigehito
Department of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, Japan.
Anesthesiology. 2004 Apr;100(4):871-8; discussion 5A-6A. doi: 10.1097/00000542-200404000-00017.
It is common clinical practice to use fluid infusion to manage high-volume blood loss until a blood transfusion is performed. The authors investigated the influence of fluid infusion associated with blood loss on the pseudo-steady state propofol concentration.
Twenty-seven swine were assigned to a lactated Ringer's solution group, a hydroxyethyl starch group, or a threefold lactated Ringer's solution group (n = 9 in each group). After 180 min of steady state infusion of propofol at a rate of 2 mg.kg(-1).h(-1), hemorrhage and infusion were induced by stepwise bleeding followed by fluid infusion every 30 min. In each of the first two steps, 400 ml blood was collected; thereafter, 200 ml was collected at each step. Just after each bleeding step, fluid infusion was rapidly performed using a volume of lactated Ringer's solution or hydroxyethyl starch equivalent to the blood withdrawn, or a threefold volume of lactated Ringer's solution. Hemodynamic parameters and the plasma propofol concentration were recorded at each step.
Although the plasma propofol concentration in the lactated Ringer's solution group increased with hemorrhage and infusion, it decreased in both the hydroxyethyl starch and the threefold lactated Ringer's solution groups. The propofol concentration in the hydroxyethyl starch group could be expressed by the following equation: Plasma Propofol Concentration Decrease (%) = 0.80 x Hematocrit Decrease (%) (r2 = 0.83, P < 0.0001).
When high-volume blood loss is managed by isovolemic hemodilution, the plasma propofol concentration during continuous propofol infusion decreases linearly with the hematocrit decrease.
在进行输血之前,通过液体输注来处理大量失血是常见的临床做法。作者研究了与失血相关的液体输注对伪稳态丙泊酚浓度的影响。
将27头猪分为乳酸林格液组、羟乙基淀粉组或三倍乳酸林格液组(每组n = 9)。以2 mg·kg⁻¹·h⁻¹的速率持续输注丙泊酚180分钟达到稳态后,通过逐步放血然后每30分钟进行一次液体输注来诱导出血和输注。在前两步中,每次采集400 ml血液;此后,每步采集200 ml。在每次放血步骤后,立即快速输注与所抽取血液等量的乳酸林格液或羟乙基淀粉,或三倍体积的乳酸林格液。记录每一步的血流动力学参数和血浆丙泊酚浓度。
虽然乳酸林格液组的血浆丙泊酚浓度随着出血和输注而升高,但在羟乙基淀粉组和三倍乳酸林格液组中均降低。羟乙基淀粉组中的丙泊酚浓度可用以下方程表示:血浆丙泊酚浓度降低百分比(%) = 0.80×血细胞比容降低百分比(%)(r² = 0.83,P < 0.0001)。
当通过等容血液稀释处理大量失血时,持续输注丙泊酚期间的血浆丙泊酚浓度随血细胞比容降低呈线性下降。